ABOUT VENTOUX BIOSCIENCES
Ventoux Biosciences is revolutionizing the treatment of Dupuytren’s disease, with a commitment to improving outcomes for patients. Founded by a Dupuytren’s patient and supported by a team of experts with experience spanning from bench to bedside, we are focused on advancing treatment options for Dupuytren’s and related immune-fibrotic diseases, addressing the significant unmet needs in these areas.
Our leading compound, VEN-201, has demonstrated promising anti-fibrotic effects and a positive safety profile in pre-clinical research. We are dedicated to pushing the boundaries of medical innovation to provide effective solutions for those affected by Dupuytren’s and related conditions.
MORE ABOUT US
Lathiya Solutions is a trusted partner for businesses seeking digital innovation. Our team of expert developers, designers, and analysts specializes in delivering custom web and mobile applications tailored to your business needs. We focus on creating high-quality solutions that drive success, ensuring that every project helps you meet your goals in the digital landscape.